February 2010 Vol XXXIV Issue 2

Previous MonthNext Month


Nutritional Recommendations for Patients with Non-Alcoholic Fatty Liver Disease:An Evidence Based Review

Ashutosh S. Naniwadekar

NAFLD is likely to emerge as the most common cause of liver disease associated mortality in the next decade. This article reviews the role of weight loss measures and nutritional supplements such as antioxidants and n-3 polyunsaturated fatty acids in the treatment of NAFLD.


Improving Adherence in Inflammatory Bowel Disease

Steven J. Bernick, Sunanda Kane

Patient adherence to treatment regimens is important in the management of chronic diseases such as IBD. This article discusses specific interventions, management tools and important strategies useful in reinforcing and achieving patient compliance.

Departments Section

Medical Bulletin Board

Millions With Occasional Digestive Upsets Can Try Align® With Confidence

P&G Offers 100% Money-Back Guarantee on its Patented, Daily Probiotic Supplement

Boston Scientific Announces Enrollment of First Patient in Benign Stricture Study of WallFlex® Biliary RX Stent

Boston Scientific Corporation announced that the first patient has been enrolled in a clinical trial to evaluate its WallFlex® Biliary RX Fully Covered Stent for the treatment of benign bile duct strictures.